ReviewFrontiers in oncology2022
Targeting FGL2 in glioma immunosuppression and malignant progression.
Xiaoyu Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewFrontiers in oncology2022
Xiaoyu Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.